Literature DB >> 1682221

Influence of the strength, drop size and viscosity of metipranolol eye drops on the concentration of the substance in human aqueous humour.

C Kessler1, H Bleckmann, G Kleintges.   

Abstract

Concentrations of metipranolol were determined in the aqueous humour of patients undergoing cataract surgery. At 30 min before the operation, patients were given 20- or 30 microliters drops of 0.1% or 0.3% metipranolol solutions with a viscosity of 7.5 cP or drops (20 or 30 microliters) of a 0.3% solution with a viscosity of 1.5 cP. Samples of the aqueous humour were obtained at the beginning of the cataract operation, and desacetyl-metipranolol content was determined by means of gas chromatography and mass spectroscope. The Wilcoxon signed-rank test and Jonckheere's method were used for evaluation of the results. A 3-fold increase in the strength of metipranolol was associated with an approx. 8-fold increase in the concentration of metabolite found in the aqueous humour. Drop size had no apparent effect on the concentration of this substance in the aqueous humour, but viscosity had a significant influence when large drops were applied. An increase in the amount of metipranolol applied as eye-drops was associated with an increase in the intraocular concentration of the metabolite.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682221     DOI: 10.1007/bf00166309

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Ocular evaluation of polyvinyl alcohol vehicle in rabbits.

Authors:  T F Patton; J R Robinson
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

2.  Corneal contact times of ophthalmic vehicles. Evaluation by microscintigraphy.

Authors:  J H Trueblood; R M Rossomondo; L A Wilson; W H Carlton
Journal:  Arch Ophthalmol       Date:  1975-02

3.  Extraocular fluid dynamics: how best to apply topical ocular medication.

Authors:  F T Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  1976

4.  Drop size of commercial glaucoma medications.

Authors:  C M Lederer; R E Harold
Journal:  Am J Ophthalmol       Date:  1986-06-15       Impact factor: 5.258

5.  Drop size and initial dosing frequency problems of topically applied ophthalmic drugs.

Authors:  S S Chrai; M C Makoid; S P Eriksen; J R Robinson
Journal:  J Pharm Sci       Date:  1974-03       Impact factor: 3.534

6.  Penetration of timolol eye drops into human aqueous humour: the first hour.

Authors:  C I Phillips; R S Bartholomew; A M Levy; J Grove; R Vogel
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

7.  Determination of metipranolol and desacetylmetipranolol in aqueous humor of rabbit eye by gas chromatography with electron-capture detection.

Authors:  R Garraffo; P Lapalus
Journal:  J Chromatogr       Date:  1986-11-28

8.  Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.

Authors:  T F Patton; M Francoeur
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

9.  Penetration of timolol eye drops into human aqueous humour.

Authors:  C I Phillips; R S Bartholomew; G Kazi; C J Schmitt; R Vogel
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

10.  Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.

Authors:  F E Ros; H C Innemee; P A van Zwieten
Journal:  Doc Ophthalmol       Date:  1980-04-15       Impact factor: 2.379

View more
  2 in total

1.  Influence of the concentration of metipranolol eye drops on the drug concentration in human aqueous humour.

Authors:  C Kessler; H Bleckmann; G Kleintges
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.

Authors:  S Dinslage; M Diestelhorst; A Weichselbaum; R Süverkrüp
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.